[Other] Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA |
Reward10points
|
| |
10
The LDL cumulative exposure hypothesis: evidence and practical applications
20
Machine Learning Based Predictive Maintenance Solution for Transformers
20
Entropy and Non-Fourier Flux on Hydro-magnetic Flow Among Nonlinearly Radiated Porous Micro Walls Filled with Blood-Based Different Shaped Ternary Nanoparticles
10
Some reliability measures and maintenance policies for a coherent system composed of different types of components
35
Three-dimensional numerical modelling of drilling-induced tensile wall fractures
